Skip to main content
. 2001 Jan;11(1):28–42. doi: 10.1101/gr.157701

Table 9.

Common Effects for Novobiocin or Ciprofloxacin

Functional Groupa Novobiocin Ciprofloxacin



Total no.of genes Increased % Decreased % Increased % Decreased %









Amino acid biosynthesis 70 5 7% 29 41% 2 3% 16 23%
 Aromatic amino acid family 16 1 6% 4 25% 0% 1 6%
 Aspartate family 18 1 6% 7 39% 1 6% 8 44%
 Branched chain family 10 0% 5 50% 0% 0%
 Glutamate family 9 2 22% 1 11% 1 11% 4 44%
 Histidine family 9 0% 9 100% 0% 1 11%
 Serine family and pyruvate family 8 1 13% 3 38% 0% 2 25%
Biosynthesis of cofactors,  prosthetic groups, and carriers 56 5 9% 16 29% 0% 2 4%
Cell envelope 79 12 15% 11 14% 2 3% 5 6%
Cellular processes 53 5 9% 12 23% 1 2% 5 9%
 Cell division 17 3 18% 6 35% 0% 0%
 Chaperones 6 0% 2 33% 0% 2 33%
 Others 30 2 7% 4 13% 1 3% 3 10%
Central intermediary metabolism 30 1 3% 12 40% 0% 7 23%
Energy metabolism 109 8 10% 21 19% 4 6% 17 16%
Fatty acid and phospholipid  metabolism 26 11 42% 5 19% 2 8% 2 8%
Hypothetical 339 4 76% 22 13% 11 3% 22 6%
Other categories 95 7 7% 14 15% 1 1% 5 5%
Purines, pyrimidines, nucleosides,  and nucleotides 52 6 12% 5 10% 1 2% 5 10%
Regulatory functions 68 6 9% 11 16% 2 3% 8 12%
Replication, recombination, and  DNA repair 84 18 21% 14 17% 13 15% 3 4%
Transcription 26 4 15% 4 15% 3 12% 1 4%
 DNA-dependent RNA polymerase 17 3 18% 3 18% 2 12% 1 6%
 Degradation of RNA 9 1 11% 1 11% 1 11% 0%
Translation 143 18 13% 23 16% 15 10% 17 12%
 Amino acyl tRNA synthetases 34 9 26% 4 12% 6 18% 3 9%
 Ribosomal proteins synthesis and   modification 57 2 4% 3 5% 3 5% 8 14%
 Others 52 7 13% 16 31% 6 12% 6 12%
Transport and binding proteins 123 10 8% 31 25% 2 2% 19 15%
 Amino acids peptides and amines 38 3 8% 12 32% 0% 8 21%
 Other transport and binding   proteins 85 7 8% 19 11% 2 2% 11 13%
Total 1353 132 10% 284 21% 62 5% 134 10%
a

As defined by Fleischmann et al. (1995)